AES grants will fund eight research projects at IRBLleida with nearly one million euros

The Strategic Health Initiative (AES) of the Carlos III Health Institute (ISCIII) has funded eight research projects at the Lleida Biomedical Research Institute (IRBLleida) with a total budget of nearly one million euros, specifically €813,205.69. In the 2025 call for proposals, IRBLleida has once again been selected as a beneficiary. Through these annual competitive grants, the ISCIII funds innovative, high-quality biomedical research projects and is committed to strengthening the scientific community and developing research careers in Lleida.

The grants will support eight health research projects across four of IRBLleida's five research areas:

Area of Chronic Diseases, Surgery and Healthcare:

• David de Gonzalo, from the Clinical and Molecular Phenotyping group.
• Adriano Targa and Gerard Torres, from the Translational Research in Respiratory Medicine group.
• Ivan Benitez and Ferran Barbé, from the Translational Research Group in Respiratory Medicine.
• Serafí Cambray and Sara Bielsa, from the Translational Vascular and Renal Research Group.
• Blanca Salinas and Ferran Rius, from the Translational Research Group in Respiratory Medicine and and the Immunology and Metabolism Research Group.
• Helena Fernández, from the Healthcare Research Group (GRECS).

Neuroscience Area:

• Gerard Piñol and Faridé Dakterzada, from the Cognition and Behaviour Study Group.

Areas of Epidemiology, Infectious Diseases and Public Health, and Nutrition, Metabolism and Stress

•  Javier Trujillano and Ester Vilaprinyó, from the research groups on Intensive Care Medicine and Systems Biology and Statistical Methods for Research.

Indeed, this latter project consolidates collaboration between groups from different research areas at IRBLleida, as well as between predominantly clinical groups and more basic research groups.